Chonluten
Chonluten (Glu-Asp-Gly) is a synthetic Khavinson tripeptide bioregulator explicitly engineered for the precise genetic optimization of the deep bronchial and alveolar lining. Utilizing an ultra-short amino acid sequence, it drives rapid pulmonary repair, forcefully mitigating structural damage from chronic smoke exposure, deep respiratory infections, and severe age-related decline in absolute lung capacity.
Quick Stats
Scientific Data
Mechanism of Action
Chonluten (Glu-Asp-Gly) is a tripeptide bioregulator targeting the lungs and gastric mucosa. It primarily acts on the respiratory epithelial cells to reduce inflammation, improve oxygen transfer capacity, and support lung tissue regeneration. It is frequently utilized in protocols for respiratory aging, post-infection recovery, and environmental toxin (e.g., smoking) damage.
Source: PMID: 15677927
Background & History
Chonluten (EDG) is the synthetic lung tripeptide targeting alveolar surfactant function.
Research Use Cases
- ✓Alveolar function support
- ✓Surfactant production
- ✓Respiratory health
Dosing Protocol
| Typical Dose | 10-20 mg/day (oral) or 1-2 mg SC |
| Frequency | 1× daily for 10-30 day cycles |
| Half-Life | ~30 minutes (estimated) |
| Common Vial Sizes | 5 mg, 10 mg |
Dosing Protocols
Khavinson Protocol
Body-Weight Dosing Reference
Estimated doses extrapolated from the published research range of 1000–20000 mcg/day (referenced to 70 kg / 154 lb). These are approximations — consult a qualified healthcare provider for personalised guidance.
| Weight | Low Dose | Target Dose | High Dose |
|---|---|---|---|
| 120 lb(54 kg) | 771 mcg | 8100 mcg | 15429 mcg |
| 140 lb(63 kg) | 900 mcg | 9450 mcg | 18000 mcg |
| 160 lb(73 kg) | 1043 mcg | 10950 mcg | 20857 mcg |
| 180 lb(82 kg) | 1171 mcg | 12300 mcg | 23429 mcg |
| 200 lb(91 kg) | 1300 mcg | 13650 mcg | 26000 mcg |
| 220 lb(100 kg) | 1429 mcg | 15000 mcg | 28571 mcg |
| 250 lb(113 kg) | 1614 mcg | 16950 mcg | 32286 mcg |
💉 For exact syringe units based on your vial concentration, use the Chonluten Reconstitution Calculator →
Administration
Expected Timeline
Who Is It For?
Respiratory Health
LowLung bioregulator. Restores age-suppressed pulmonary gene expression.
Reconstitution Example
Safety & Considerations
Research peptide. Extensively used in Russian clinical protocols. Excellent safety profile.
Regulatory & Legal Status
Not currently on the WADA 2026 Prohibited List. Policies may change — verify before competition.
Research Chemical
US Compounding: Not eligible / not available
⚠️ This information is for educational purposes only and may not reflect the most current regulatory updates. Always verify with official FDA, WADA, and jurisdiction-specific sources before use.
Interactions & Contraindications
Standard Khavinson protocol.
Synergies & Common Stacks
Chonluten (alveolar) + Bronchogen (bronchial) = complementary respiratory tract coverage.
Dosing Quick Reference
Frequently Asked Questions
How does Chonluten compare to Bronchogen?▼
References
- Khavinson VKh et al. “"Peptide bioregulators for lung tissue aging".” Advances in Gerontology (2006). PMID: 16927532
📚 Related Articles
Get Chonluten from Vita-Stream — the comprehensive distributor for authentic Khavinson bioregulators. Oral capsules, no injections required.
Affiliate link · Full review